-transparent.png){kind=logo}
The randomized clinical trial with interferon-alpha (IFN) or thymic hormones versus conventional therapy was conducted in patients with myocarditis and idiopathic dilated cardiomyopathy (IDC). We enrolled 180 patients to receive IFN (3-5 million units per day) for 3 months, thymomodulin (10 mg three times per week) for 2 months, or conventional therapy alone. Patients were followed-up for 7 years after the end of treatment. Left ventricular function, exercise tolerance and survival rate were significantly better at long-term follow-up in patients treated with IFN or thymomodulin, than in conventionally treated patients. These results implicate that immune modulating therapy might represent important contribution in the treatment of myocarditis and IDC.
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
September 2006,
International heart journal,
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
July 1995,
Journal of the American College of Cardiology,
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
October 2004,
Heart (British Cardiac Society),
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
November 1985,
Schweizerische medizinische Wochenschrift,
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
April 2007,
Cardiology in the young,
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
September 1995,
The American journal of medicine,
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
December 1988,
International journal of cardiology,
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
August 2015,
Revista espanola de cardiologia (English ed.),
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
December 1992,
Zeitschrift fur Kardiologie,
M Mirić, and
A Misković, and
S Brkić, and
J Vasiljević, and
N Keserović, and
M Pesić
April 1991,
Cardiovascular drugs and therapy,
